Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Organofluorides Stories

2013-12-18 12:25:41

MUMBAI and BALTIMORE, December 18, 2013 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary Lupin Pharmaceuticals Inc. has launched its Abacavir Sulfate, Lamivudine, and Zidovudine Tablets, 300 mg (base) / 150 mg / 300 mg in the US after the US District Court for the District of Delaware ruled that the Lupin's generic version of Trizivir(R) did not infringe on patents. Lupin had earlier received approval for the same. Lupin's...

2013-12-17 23:01:20

The Firm is currently investigating Risperdal lawsuits on behalf of young men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of the antipsychotic drug. New York, New York (PRWEB) December 17, 2013 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) involving allegations that the atypical antipsychotic medication caused patients to develop gynecomastia (male breast growth) and other serious side effects continue to move forward,...

2013-12-17 23:00:28

DeepResearchReports.com adds “2013 Deep Research Report on Global and China Sevoflurane Industry” report to its research store. "In-depth Research and Forecast of China Phosphorus Chemical Industry, 2013” is a new report added to MarketReportsChina.com. Dallas, Texas (PRWEB) December 18, 2013 “2013 Deep Research Report on Global and China Sevoflurane Industry” is a professional and in-depth research report on China and Global sevoflurane market. The report introduces...

2013-12-16 08:26:08

Penetration into Tier 2 and Tier 3 Cities of China May Increase Uptake of Targeted Therapies for HCC and Drive Market Growth, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 16, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in China, the uptake of premium-priced targeted therapies for hepatocellular carcinoma (HCC) is heavily influenced by their high cost...

2013-12-15 23:01:57

The Firm is now investigating Lipitor lawsuits on behalf of individuals who developed new-onset Type 2 diabetes, allegedly due to their use of the cholesterol-lowering statin. New York, New York (PRWEB) December 15, 2013 A new Lipitor lawsuit (http://www.thelipitorlawsuit.com/) filed in Kentucky claims that a woman’s Type 2 diabetes could have been avoided were it not for allegedly inadequate warnings provided by Pfizer, Inc., Bernstein Liebhard LLP reports. The complaint, which was...

2013-12-14 23:01:57

The firm is currently offering Risperdal lawsuit evaluations to those who allege that they suffered from the drug’s alleged side effects. (PRWEB) December 14, 2013 Risperdal plaintiffs have asked a Pennsylvania judge to unseal clinical studies data, citing its importance to the public interest, according to court documents. The Rottenstein Law Group LLP, which represents clients in Risperdal lawsuits, notes that the documents detail potential risks associated with the antipsychotic...

2013-12-13 08:24:48

VENTANA HER2 (4B5) IHC assay label expansion coincides with therapy availability in many non-U.S. countries globally TUCSON, Ariz., Dec. 13, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces the VENTANA HER2/neu (4B5) Rabbit Monoclonal Primary Antibody assay as a companion diagnostic(1) for detecting HER2 protein expression for patients who, in countries where they are approved, may be appropriate candidates for Perjeta(®) (pertuzumab)...

2013-12-12 23:28:53

Rapid CYP2C19 Testing for Heart Attack Patients Using Antiplatelet Drugs in 150-Patient Clinical Trial With Spartan Bioscience Ottawa, Ontario (PRWEB) December 12, 2013 Spartan Bioscience today announced the start of a 150-patient study of personalized medicine for cardiac stent patients in Poland, Hungary, and Lithuania. The study is sponsored by the Medical University of Warsaw, and is entitled “Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During...

2013-12-12 23:00:57

Bernstein Liebhard LLP is evaluating Risperdal lawsuits on behalf of young men and boys who developed gynecomastia, or male breast growth, allegedly due to their use of the antipsychotic drug. New York, New York (PRWEB) December 12, 2013 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) , including many that allege use of the antipsychotic drug caused some men and young boys to develop gynecomastia, or male breast growth, continue to move forward in a consolidated litigation...

2013-12-12 20:24:59

ZURICH, December 12, 2013 /PRNewswire/ -- - First Head to Head Study Showed Tecta(R) As Effective for Healing and Complete Remission of Erosive GERD with Significantly Higher Symptom Relief After 8 Weeks compared to Esomeprazole[1] - Takeda Pharmaceuticals International GmbH (Takeda) announced today results showing pantoprazole magnesium 40 mg (Tecta(R)) was as effective as esomeprazole 40 mg for achieving complete remission...